NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zynex Inc (NASDAQ: ZYXI)

ZYXI Technical Analysis
As on 29th May 2024 ZYXI SHARE Price closed @ 10.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 10.47 & Strong Sell for SHORT-TERM with Stoploss of 14.04 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 10.11 Change Price %
High 10.11 1 Day -0.09 -0.89
Low 9.93 1 Week -0.86 -7.90
Close 10.02 1 Month -2.13 -17.53
Volume 121100 1 Year -3.63 -26.59
52 Week High 16.80 | 52 Week Low 6.95
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
FFIE 0.44 -62.39%
RSLS 0.28 33.33%
AAL 11.62 -13.54%
CRKN 0.09 -18.18%
LMDX 0.02 0.00%
ASTS 9.02 69.23%
KTRA 0.27 42.11%
PONO 1.72 2.38%
NKLA 0.50 -1.96%
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
ASTSW 2.95 147.90%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
CFFEW 0.11 120.00%
JCIC 22.08 116.68%
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
AUVI 0.05 -82.76%
ACAQ-UN 2.50 -73.49%
AXAS 0.03 -70.00%
FFIE 0.44 -62.39%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
GMBLW 0.01 -50.00%
FFIEW 0.03 -50.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
ZYXI Important Levels Intraday
ZYXI Forecast June 2024
4th UP Forecast23.05
3rd UP Forecast18.87
2nd UP Forecast16.29
1st UP Forecast13.7
1st DOWN Forecast6.34
2nd DOWN Forecast3.75
3rd DOWN Forecast1.17
4th DOWN Forecast-3.01
ZYXI Weekly Forecast
4th UP Forecast11.68
3rd UP Forecast11.15
2nd UP Forecast10.82
1st UP Forecast10.49
1st DOWN Forecast9.55
2nd DOWN Forecast9.22
3rd DOWN Forecast8.89
4th DOWN Forecast8.36
ZYXI Forecast2024
4th UP Forecast30
3rd UP Forecast23.59
2nd UP Forecast19.63
1st UP Forecast15.67
1st DOWN Forecast4.37
2nd DOWN Forecast0.41
3rd DOWN Forecast-3.55
4th DOWN Forecast-9.96
ZYXI Other Details
Segment EQ
Market Capital 429638528.00
Sector Healthcare
Industry Medical Devices
Offical website >
ZYXI Address
ZYXI Latest News
Your Comments and Response on Zynex Inc
ZYXI Business Profile
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado. Address: 9555 Maroon Circle, Englewood, CO, United States, 80112
2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service